Enhancing Cancer Immunotherapy by Intracellular Delivery of Cell-Penetrating Peptides and Stimulation of Pattern-Recognition Receptor Signaling
- 23 March 2012
- book chapter
- review article
- Published by Elsevier BV in Advances in Immunology
- Vol. 114, 151-176
- https://doi.org/10.1016/b978-0-12-396548-6.00006-8
Abstract
No abstract availableThis publication has 141 references indexed in Scilit:
- NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 and IKKImmunity, 2011
- Prevention of cancer by prophylactic human papillomavirus vaccinesCurrent Opinion in Immunology, 2011
- Cell Surface Signaling Molecules in the Control of Immune Responses: A Tide ModelImmunity, 2011
- NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling PathwaysCell, 2010
- A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell–mediated suppressionNature Medicine, 2008
- Pathogen Recognition and Innate ImmunityCell, 2006
- Cell-penetrating peptides: tools for intracellular delivery of therapeuticsCellular and Molecular Life Sciences, 2005
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responsesNature Immunology, 2004
- Inflammation and cancerNature, 2002